METAVIA INC. Capital Expenditures
METAVIA INC. (MTVA) reported Capital Expenditures of $2.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- METAVIA INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
- METAVIA INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- METAVIA INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- METAVIA INC. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- METAVIA INC. payments to acquire property, plant, and equipment for fiscal 2025 was $2.00K, a 75.00% decline from fiscal 2024.
- METAVIA INC. payments to acquire property, plant, and equipment for fiscal 2024 was $8.00K, a 84.00% decline from fiscal 2023.
- METAVIA INC. payments to acquire property, plant, and equipment for fiscal 2023 was $50.00K.
- METAVIA INC. payments to acquire property, plant, and equipment for fiscal 2021 was $3.00K, a 25.00% decline from fiscal 2020.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $2.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.00K 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $3.00K derived: sum of 3 quarters · filed 2026-03-26 | $8.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.00K derived: sum of 2 quarters · filed 2025-11-06 | $8.00K 10-Q · filed 2025-11-06 | $17.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $8.00K 10-Q · filed 2025-08-07 | $17.00K derived: sum of 3 quarters · filed 2025-08-07 | $54.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $5.00K 10-Q · filed 2025-05-14 | $14.00K derived: sum of 2 quarters · filed 2025-05-14 | $51.00K derived: sum of 3 quarters · filed 2025-05-14 | $51.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $46.00K derived: sum of 2 quarters · filed 2025-03-20 | $46.00K derived: sum of 3 quarters · filed 2025-03-20 | $50.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $37.00K derived: sum of 2 quarters · filed 2024-11-07 | $41.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $4.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $3.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $3.00K 10-Q · filed 2022-08-12 | |||
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.00K derived: sum of 2 quarters · filed 2022-03-31 | $2.00K derived: sum of 3 quarters · filed 2022-03-31 | $4.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $2.00K 10-Q · filed 2021-11-15 | $98.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $2.00K 10-Q · filed 2021-08-16 | $98.00K derived: sum of 3 quarters · filed 2021-08-16 | $191.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-17 | $98.00K derived: sum of 2 quarters · filed 2021-05-17 | $191.00K derived: sum of 3 quarters · filed 2021-05-17 | |
| 2019-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | $189.00K derived: sum of 2 quarters · filed 2021-04-15 | $214.00K 10-K · filed 2021-04-15 | |
| 2019-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $118.00K 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | $25.00K 10-Q · filed 2020-08-11 | |||
| 2018-12-31 | $3.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |